Medicine and Recreation are the two chief cannabis applications at present.
As many as 180.6 million people over the world used cannabis as per the World Drug Report in 2013 [1]. Humankind’s medicinal, recreational, industrial, and religious practices have used the plant for ages. Most
importantly, it is less likely to produce behavioral and psychological harm vis-à-vis other controlled psychoactive substances.
Rising awareness of the benign health effects of cannabis is turning the tide in favor of its legalization and decriminalization. Public opinion is a powerful force of legitimization – illegal markets that people do not strongly disapprove of are tougher to eliminate [2].
Next, cannabis smuggling is inextricably connected to organized crime. Uruguay was the first country to legalize recreational cannabis in 2012 [3]. Better to legally regulate product quality than to drive the market underground and leave users at the mercy of unscrupulous suppliers. Besides, organized crime comes with its share of violence.
But while these factors create a climate of opinion in support of cannabis, a host of reasons breed confusion in the legal landscape at the international, national, and regional levels. These inconsistencies in law hold back cannabis from attaining its full potential.
Following treaties of the United Nations (UN) form the guidelines for cannabis-related policies of most countries, which cover the farming, distribution, possession, and use of cannabis [4]:
At the root of this legal uncertainty is the differing chemical composition of its variants – hemp and marijuana. Hemp contains under 0.3% tetrahydrocannabinol (THC) by dry weight; marijuana contains over 0.3% [5].
Many countries prohibit marijuana use as THC is psychoactive as it gets people “high.” Hemp does not face such wholesale legal hostility [6]. Cannabis also contains cannabidiol (CDB), which, unlike THC, is not psychoactive, but improves health.
Chemical uncertainty leads to geographical inconsistencies in the legal status of cannabis:
Such geographical variations cripple the movement of cannabis and its products across state and international borders. As a result, the medicinal, recreational, and commercial potential of cannabis remains mostly untapped.
Around 2018, the ability of cannabis to treat epilepsy in children made news in the United Kingdom. Researchers are also looking into its capacity to counter HIV/AIDS, cancer, and multiple sclerosis [3]. This is in addition to its medicinal application against pain, depression, anxiety, migraines, seizures, and inflammatory bowel disease [7].
A detailed list of the status of medical and recreational cannabis is available on the website of The Cannigma.
Medical Cannabis: As many as thirty-three states and the District of Columbia in the United States authorize the therapeutic or medicinal use of cannabis [8]. Federal laws in the country, however, disallow cannabis utilization for any reason whatsoever.
The following countries permit the medical use of cannabis [9]:
Next, there are countries that allow medical cannabis, but only with tight restrictions [9]:
The related legal status of medical cannabis in some other countries:
Medical cannabis legalities in Europe have two more dimensions [13]:
Recreational Cannabis: Can legitimately move across international borders only when licensed by the International Narcotics Control Board [3]. Federal laws in the United States disallow recreational cannabis. However, eleven states, the District of Columbia [8], and two territories viz. Guam and the Northern Mariana Islands permit it [14].
Only a handful countries have legalized recreational cannabis [9]:
Next, there are countries that have decriminalized recreational cannabis only for personal use [9]:
Specific cases of recreational cannabis decriminalization include [9]:
Policymakers around the world have a fair balancing act on their hands when treading the wafer-thin line of cannabis legalization. For addiction to psychoactive versions of the plant is a serious downside when weighing its exceptional medicinal upside.
Buffalo Extraction Systems (BES) operates with trusted partners in the Carbon dioxide (CO2) Supercritical Fluid Extraction (SCFE) space and offers turnkey solutions for the extraction of Cannabis, Spices, Flavors and Fragrances, Essential Oils, Aromatherapy, Herbal Medicines, Algae, Phytochemicals, and Neutraceuticals.
Contact Buffalo Extraction Systems at info@buffaloextracts.com for cutting edge CO2 extraction technology.
References